drugset / Trial / NCT02227173
A Phase 1 Drug-drug Interaction Study in Healthy Volunteers
Non-randomizedSingle-groupOpen-label
Summary
This is an open-label, single-sequence, drug-drug interaction study in healthy male and female subjects. There is no formal research hypothesis to be statistically tested. It is expected that coadministration of BMS-986020 with montelukast, flurbiprofen, and digoxin may increase the exposure of montelukast, flurbiprofen, and digoxin.
Timeline
- Start
- 2014-09
- Primary completion
- 2014-11
- Completion
- 2014-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BMS-986020 | Small molecule | — | Oral |
| Subject | Digoxin | Other / unclassified | — | Oral |
| Subject | Flurbiprofen | Small molecule | — | Oral |
| Subject | Montelukast | Other / unclassified | — | Oral |
Indications
No indication recorded.